Patent ID: 11890324
Assignee: EPOQE PHARMA APS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for the treatment of acute myocardial infarction (AMI), the method comprising:
administering a calcitonin gene-related peptide (CGRP) compound,
wherein the CGRP compound is N-alpha-[2-(2-{2-[(S)]-4-carboxy-4-(17-carboxyheptadecanoylamino)-butyryl-amino]-ethoxy}ethoxy)acetyl][Ser1]beta-human CGRP peptide (β-CGRP-analogue), and a pharmaceutically acceptable salts and solvates thereof,
wherein the CGRP compound is administered at least once per day, and
wherein the CGRP is administered for one to thirty consecutive days immediately after incident.